We are live on ! Find out more
BCB

Brian C. Broderick Portfolio holdings

AUM $542M
1-Year Est. Return 20.28%
This Fund
S&P 500
This Quarter Est. Return
+9.6%
1 Year Est. Return
+20.28%
3 Year Est. Return
+64.8%
5 Year Est. Return
+86.99%
10 Year Est. Return
+301.53%
AUM
$201M
AUM Growth
+$21.6M
Cap. Flow
+$4.01M
Cap. Flow %
2%
Top 10 Hldgs %
34.54%
Holding
94
New
3
Increased
25
Reduced
34
Closed
3

Top Buys

Rank Stock Value
1
EPZM
Epizyme, Inc
EPZM
+$1.45M
2
QCOM icon
Qualcomm
QCOM
+$1.25M
3
GSK icon
GSK
GSK
+$958K
4
JCI icon
Johnson Controls International
JCI
+$689K
5
SLB icon
SLB Ltd
SLB
+$507K

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$720K
2
DVN icon
Devon Energy
DVN
+$514K
3
JNJ icon
Johnson & Johnson
JNJ
+$430K
4
CNI icon
Canadian National Railway
CNI
+$342K
5
PRGO icon
Perrigo
PRGO
+$341K

Sector Composition

Rank Sector Weight
1 Healthcare 22.57%
2 Industrials 18.92%
3 Technology 17.72%
4 Energy 14.64%
5 Consumer Staples 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PBA icon
26
Pembina Pipeline
PBA
$29.6B
$2.8M 1.39%
79,466
-2,900
-4% -$95.3K
FISV
27
Fiserv Inc
FISV
$26.8B
$2.32M 1.16%
78,590
+17,510
+29% +$472K
MA icon
28
Mastercard
MA
$470B
$2.18M 1.08%
26,070
+30
+0.1% +$2.23K
CSCO icon
29
Cisco
CSCO
$442B
$2.17M 1.08%
96,557
+160
+0.2% +$3.54K
IRWD icon
30
Ironwood Pharmaceuticals
IRWD
$639M
$2.16M 1.07%
221,899
– –
ABB
31
DELISTED
ABB Ltd
ABB
$2.15M 1.07%
81,130
-8,290
-9% -$206K
NXPI icon
32
NXP Semiconductors
NXPI
$70.4B
$2.13M 1.06%
46,360
-450
-1% -$18.5K
JCI icon
33
Johnson Controls International
JCI
$86.9B
$2.08M 1.04%
38,797
+14,000
+56% +$689K
QCOM icon
34
Qualcomm
QCOM
$185B
$2.06M 1.03%
27,750
+17,735
+177% +$1.25M
MSFT icon
35
Microsoft
MSFT
$2.9T
$1.81M 0.9%
48,347
– –
HON icon
36
Honeywell
HON
$73.8B
$1.66M 0.83%
20,246
– –
MRK icon
37
Merck
MRK
$315B
$1.64M 0.82%
34,328
-1,048
-3% -$47.9K
UNP icon
38
Union Pacific
UNP
$174B
$1.61M 0.8%
19,134
-400
-2% -$31.7K
ABBV icon
39
AbbVie
ABBV
$448B
$1.53M 0.76%
28,970
– –
MON
40
DELISTED
Monsanto Co
MON
$1.48M 0.73%
12,667
– –
PRGO icon
41
Perrigo
PRGO
$1.45B
$1.46M 0.73%
9,530
-2,365
-20% -$341K
VFC icon
42
VF Corp
VFC
$6.74B
$1.39M 0.69%
23,619
– –
ABT icon
43
Abbott
ABT
$175B
$1.36M 0.68%
35,545
+475
+1% +$17.5K
BMY icon
44
Bristol-Myers Squibb
BMY
$124B
$1.34M 0.67%
25,200
– –
DD
45
DELISTED
Du Pont De Nemours E I
DD
$1.29M 0.64%
20,908
– –
CVE icon
46
Cenovus Energy
CVE
$54.1B
$1.21M 0.6%
42,242
-838
-2% -$24.4K
IBM icon
47
IBM
IBM
$193B
$1.18M 0.59%
6,550
– –
SIAL
48
DELISTED
SIGMA - ALDRICH CORP
SIAL
$1.13M 0.56%
12,010
– –
KO icon
49
Coca-Cola
KO
$354B
$1.08M 0.54%
26,215
– –
EPZM
50
DELISTED
Epizyme, Inc
EPZM
$1.04M 0.52%
+50,000
New +$1.45M
1
2
3 4

Similar funds

MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
GPWA
Great Point Wealth Advisors Boston, Massachusetts $542M AUM
WCA
Westover Capital Advisors Wilmington, Delaware $543M AUM 36.85% 1-Year Est. Return
ISB
Iowa State Bank Urbandale, Iowa $543M AUM 21.44% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return
FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
HCM
Hutchinson Capital Management San Rafael, California $544M AUM 9.54% 1-Year Est. Return
FSA
Financial Security Advisor Virginia Beach, Virginia $544M AUM 18.82% 1-Year Est. Return

Brian C. Broderick's Q4 2013 Portfolio in Review

As of Q4 2013, Brian C. Broderick held 94 positions worth $201M, up 12% from $179M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Brian C. Broderick's Q4 2013 filing shows 3 new, 25 increased, 34 reduced and 3 closed positions. Its largest new stake was Epizyme, Inc: 50,000 shares worth $1.04M. The largest sale was Teva Pharmaceuticals, an estimated $720K.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Industrials and Technology.

  • Brian C. Broderick's largest Q4 2013 buy was Epizyme, Inc: 50,000 shares worth $1.04M.
  • Brian C. Broderick added most to Qualcomm in Q4 2013, an estimated $1.25M increase.
  • Brian C. Broderick's biggest Q4 2013 reduction was Teva Pharmaceuticals, cutting an estimated $720K.
  • Brian C. Broderick fully exited Devon Energy in Q4 2013, selling an estimated $514K.
  • Brian C. Broderick's ten largest holdings make up 35% of its $201M portfolio in Q4 2013.
  • Brian C. Broderick opened 3 new positions and closed 3 in Q4 2013.
  • Brian C. Broderick's portfolio value rose 12% quarter-over-quarter to $201M.

Based on Brian C. Broderick's 13F filing for Q4 2013, filed 27 Feb 2014.